References
- IARC WCT-. 2018 [Available from: https://gco.iarc.fr/today/data/factsheets/cancers/20-Breast-fact-sheet.pdf]
- Moschetti I, Cinquini M, Lambertini M, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database System Rev. 2016;5:CD001768.
- Taggart F, Donnelly P, Dunn J. Options for early breast cancer follow-up in primary and secondary care – a systematic review. BMC Cancer. 2012;12:238.
- Watson EK, Rose PW, Neal RD, et al. Personalised cancer follow-up: risk stratification, needs assessment or both?. Br J Cancer. 2012;106:1–5.
- Montgomery DA, Krupa K, Cooke TG. Follow-up in breast cancer: does routine clinical examination improve outcome? A systematic review of the literature. Br J Cancer. 2007;97:1632–1641.
- Kapoor T, Wrenn S, Callas P, et al. Analysis of patient-detected breast cancer recurrence. Breast Dis. 2017;37:77–82.
- Fiszer C, Dolbeault S, Sultan S, et al. Prevalence, intensity, and predictors of the supportive care needs of women diagnosed with breast cancer: a systematic review. Psychooncology. 2014;23:361–374.
- Rojas MP, Telaro E, Russo A, et al. Follow-up strategies for women treated for early breast cancer. Cochrane Database Syst Rev. 2005;1:CD001768.
- Høeg BL, Bidstrup PE, Allerslev Horsboel T, et al. Follow‐up strategies following completion of primary cancer treatment in adult cancer survivors. Cochrane Library. 2016;11:CD012425. DOI: 10.1002/14651858.CD012425
- Lewis R, Neal RD, Williams NH, et al. Nurse-led vs. conventional physician-led follow-up for patients with cancer: systematic review. J Adv Nursing. 2009;65:706–723.
- Grunfeld E, Levine MN, Julian JA, et al. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. JCO. 2006;24:848–855.
- Sheppard C, Higgins B, Wise M, et al. Breast cancer follow up: a randomised controlled trial comparing point of need access versus routine 6-monthly clinical review. Eur J Oncol Nurs. 2009;13:2–8.
- Howell D, Harth T, Brown J, et al. Self-management education interventions for patients with cancer: a systematic review. Support Care Cancer. 2017;25:1323–1355.
- Zoffmann V. Guided self-determination: a life skills approach developed in difficult type 1 diabetes. Århus: Department of Nursing Science, University of Århus; 2004.
- Zoffmann V, Lauritzen T. Guided self-determination improves life skills with type 1 diabetes and A1C in randomized controlled trial. Patient Educ Couns. 2006;64:78–86.
- Olesen ML, Duun-Henriksen AK, Hansson H, et al. A person-centered intervention targeting the psychosocial needs of gynecological cancer survivors: a randomized clinical trial. J Cancer Surviv. 2016;10:832–841.
- Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. JCO. 2016;34:557–565.
- Berry DL, Blumenstein BA, Halpenny B, et al. Enhancing patient–provider communication with the electronic self-report assessment for cancer: a randomized trial. JCO. 2011;29:1029–1035.
- Sundhedsstyrelsen. Pakkeforløb for brystkraeft; 2018. [Available from: https://www.sst.dk/da/udgivelser/2018/∼/media/1C04F012BDEF4F14AED632C457FD0CF2.ashx]
- Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85:365–376.
- Sprangers MA, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. JCO. 1996;14:2756–2768.
- Høeg BL, Johansen C, Skaarup JA, et al. The impact of patient socioeconomic status on PPI in research. Eur J Public Health. 2016;26(Supplement 1):8–10.
- Org. F. FACIT Org.; 2018 [Available from: http://www.facit.org/facitorg/questionnaires]
- Brady MJ, Cella DF, Mo F, et al. Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument. JCO. 1997;15:974–986.
- Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39:22–25.
- Moller S, Jensen MB, Ejlertsen B, et al. The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol. 2008;47:506–524.
- Bjerregaard B, Larsen OB. The Danish Pathology Register. Scand J Public Health. 2011;39:72–74.
- Schmidt M, Schmidt SA, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;7:449–490.
- Andersen JS, Olivarius Nde F, Krasnik A. The Danish National Health Service Register. Scand J Public Health. 2011;39:34–37.
- Eton DT, Cella D, Yost KJ, et al. A combination of distribution- and anchor-based approaches determined minimally important differences (MIDs) for four endpoints in a breast cancer scale. J Clin Epidemiol. 2004;57:898–910.
- Fallowfield LJ, Leaity SK, Howell A, et al. Assessment of quality of life in women undergoing hormonal therapy for breast cancer: validation of an endocrine symptom subscale for the FACT-B. Breast Cancer Res Treat. 1999;55:189–199.
- Denis F, Lethrosne C, Pourel N, et al. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. J Natl Cancer Inst. 2017;109.